BUSINESS● LOWSep 10 · Sep 10, 2026, 4:35 PM
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
Yahoo Finance · global
Biopharmaceutical company Kiniksa is expected to reach a new buy point following a strong revenue performance. This indicates positive financial momentum for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS24m agoHernán Casciari responds to those who denounced him: "I do not accept talk of fraud"ClarínBUSINESS29m agoKey deals this week: International Paper, IonQ, Bumble, and moreSeeking Alpha Tech